| scholarly article | Q13442814 |
| P50 | author | Charles M. Rice | Q22669757 |
| P2093 | author name string | J Dubuisson | |
| P2860 | cites work | Flavivirus genome organization, expression, and replication | Q24575500 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini | Q27485927 | ||
| Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses | Q27485996 | ||
| Two hepatitis C virus glycoprotein E2 products with different C termini | Q27485998 | ||
| Expression and identification of hepatitis C virus polyprotein cleavage products | Q27486022 | ||
| Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites | Q27486027 | ||
| Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions | Q27486051 | ||
| NS3 is a serine protease required for processing of hepatitis C virus polyprotein | Q27486059 | ||
| Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus | Q27486062 | ||
| Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses | Q27486074 | ||
| Structure and organization of the hepatitis C virus genome isolated from human carriers | Q27486168 | ||
| Genetic organization and diversity of the hepatitis C virus | Q27860507 | ||
| Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis | Q27860603 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 | ||
| Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase | Q27860943 | ||
| Folding and assembly of viral membrane proteins | Q27865318 | ||
| Retention of unassembled components of integral membrane proteins by calnexin | Q28258174 | ||
| Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control | Q28259305 | ||
| Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin) | Q28268858 | ||
| Protein folding in the cell | Q29547792 | ||
| Vaccination of chimpanzees against infection by the hepatitis C virus | Q29615899 | ||
| Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease | Q29620655 | ||
| A second hepatitis C virus-encoded proteinase | Q29620770 | ||
| Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end | Q29620816 | ||
| Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus | Q29620964 | ||
| Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome | Q29620976 | ||
| Vaccinia Virus Replication I. Requirement for the Host-Cell Nucleus | Q30850654 | ||
| Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum | Q33937712 | ||
| Calnexin: a membrane-bound chaperone of the endoplasmic reticulum | Q34342505 | ||
| Molecular genetics of pestiviruses | Q35232649 | ||
| Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide | Q36231365 | ||
| Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum | Q36235150 | ||
| Misfolding and aggregation of newly synthesized proteins in the endoplasmic reticulum | Q36531301 | ||
| Proper and improper folding of proteins in the cellular environment | Q36534620 | ||
| Protein Localization and Virus Assembly at Intracellular Membranes | Q36869594 | ||
| Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly | Q37026009 | ||
| Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum | Q38295642 | ||
| Identification of the region on the class I histocompatibility molecule that interacts with the molecular chaperone, p88 (calnexin, IP90). | Q38316779 | ||
| Molecular chaperones in protein folding: the art of avoiding sticky situations | Q40621904 | ||
| Reduction of endogenous GRP78 levels improves secretion of a heterologous protein in CHO cells | Q40660297 | ||
| Structural proteins of hepatitis C virus | Q40729931 | ||
| Complex processing and protein:protein interactions in the E2:NS2 region of HCV. | Q41436960 | ||
| Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells | Q41517841 | ||
| Association of folding intermediates of glycoproteins with calnexin during protein maturation | Q41533203 | ||
| Characterization of monoclonal antibodies to bovine viral diarrhoea virus: evidence of a neutralizing activity against gp48 in the presence of goat anti-mouse immunoglobulin serum | Q42114309 | ||
| The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor | Q43048247 | ||
| Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. | Q43048661 | ||
| The p88 molecular chaperone is identical to the endoplasmic reticulum membrane protein, calnexin | Q54270032 | ||
| Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum | Q59053405 | ||
| Fluorographic detection of radioactivity in polyacrylamide gols with the water-soluble fluor, sodium salicylate | Q67000083 | ||
| Hormonal regulation of thyroglobulin export from the endoplasmic reticulum of cultured thyrocytes | Q72212301 | ||
| Anti-chaperone behavior of BiP during the protein disulfide isomerase-catalyzed refolding of reduced denatured lysozyme | Q72724443 | ||
| P433 | issue | 2 | |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 778-786 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin | |
| P478 | volume | 70 |
| Q27469530 | A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. |
| Q39550327 | Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein |
| Q37805839 | Adaptive Immunity to the Hepatitis C Virus |
| Q36910780 | Affinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNA |
| Q27472891 | Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles |
| Q27472840 | Analysis of the C-terminal membrane anchor domains of hepatitis C virus glycoproteins E1 and E2: toward a topological model |
| Q37433442 | Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain |
| Q27469899 | Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers |
| Q27468952 | Assembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathway |
| Q27472768 | Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry |
| Q27469594 | Cell fusion activity of hepatitis C virus envelope proteins |
| Q26771251 | Chaperones in hepatitis C virus infection |
| Q40539381 | Characterization of functional hepatitis C virus envelope glycoproteins. |
| Q37336814 | Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopment |
| Q34436127 | Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins |
| Q34120689 | Characterization of the envelope glycoproteins associated with infectious hepatitis C virus |
| Q27469653 | Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins |
| Q28115022 | Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver Cells |
| Q36559948 | Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. |
| Q34003896 | ER stress, autophagy, and RNA viruses |
| Q35548601 | Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus |
| Q27473287 | Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle |
| Q27469682 | Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates |
| Q42497633 | Expression and membrane association of hepatitis C virus envelope 1 protein |
| Q33206994 | Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells |
| Q27469367 | Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization. |
| Q27472959 | Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum |
| Q27469881 | Folding of hepatitis C virus E1 glycoprotein in a cell-free system. |
| Q34156701 | Folding of viral envelope glycoproteins in the endoplasmic reticulum |
| Q27480776 | Formation of native hepatitis C virus glycoprotein complexes. |
| Q92216492 | Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus |
| Q63246556 | Gene Expression Profiling of Endoplasmic Reticulum Stress in Hepatitis C Virus-Containing Cells Treated with an Inhibitor of Protein Disulfide Isomerases |
| Q41666695 | Gene vaccination for hepatitis C. |
| Q27472940 | Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector |
| Q53683152 | Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies. |
| Q38384140 | HCV glycoprotein structures: what to expect from the unexpected |
| Q27477644 | Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles |
| Q29347273 | Hepatitis C Virus Envelope Protein E1 Binds PERK and Represses the Unfolded Protein Response |
| Q39755223 | Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions |
| Q27472864 | Hepatitis C virus-like particle morphogenesis |
| Q27333881 | Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein |
| Q37584342 | Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents |
| Q27478192 | Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents |
| Q27480864 | Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode |
| Q38195180 | Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion |
| Q27480410 | Interaction between hepatitis C virus core protein and E1 envelope protein |
| Q27469541 | Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins |
| Q27470798 | Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein |
| Q34558519 | Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system |
| Q37512845 | Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG. |
| Q27477612 | Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope Protein |
| Q27472869 | Persistent and transient replication of full-length hepatitis C virus genomes in cell culture |
| Q37408926 | Post-translational modifications of hepatitis C viral proteins and their biological significance |
| Q39790496 | RNA interference effectively degrades mRNA and inhibits protein expression of GBV-C E2 gene in Huh7 cells |
| Q27473084 | Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody. |
| Q30375044 | Recombinant hepatitis C virus-envelope protein 2 interactions with low-density lipoprotein/CD81 receptors. |
| Q27470013 | Robust hepatitis C virus infection in vitro |
| Q27469844 | Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins |
| Q40712831 | Role of disulfide bond formation in the folding and assembly of the envelope glycoproteins of a pestivirus |
| Q27473078 | Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope. |
| Q97528833 | Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development |
| Q27666400 | Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly |
| Q40189989 | Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2. |
| Q27472868 | Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus |
| Q27473047 | Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus |
| Q27490948 | The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule |
| Q38302147 | The alpha(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120. |
| Q34000089 | The hepatitis C virus E1 glycoprotein undergoes productive folding but accelerated degradation when expressed as an individual subunit in CHO cells |
| Q27469349 | The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum |
| Q40278516 | The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals |
| Q27472616 | Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins |
| Q39594960 | Transient association of calnexin and calreticulin with newly synthesized G1 and G2 glycoproteins of uukuniemi virus (family Bunyaviridae). |
| Q27478363 | Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus Entry |
| Q24800686 | Transmission of human hepatitis C virus from patients in secondary cells for long term culture |
| Q38218108 | Unfolded protein response in hepatitis C virus infection |
| Q38112493 | Use of baculovirus expression system for generation of virus-like particles: successes and challenges |
| Q35776114 | Vaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice. |
| Q38086754 | Virion assembly and release |
Search more.